Role of the ocular surface microbiome in allergic eye diseases.
Journal
Current opinion in allergy and clinical immunology
ISSN: 1473-6322
Titre abrégé: Curr Opin Allergy Clin Immunol
Pays: United States
ID NLM: 100936359
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
31
8
2023
pubmed:
17
7
2023
entrez:
17
7
2023
Statut:
ppublish
Résumé
The purpose of this review is to provide an update on emerging literature on the role of the ocular surface microbiome (OSM) in allergic eye diseases. Findings in the literature suggest that the ocular surface microbiome plays a role in the pathophysiology and course of allergic disease of the ocular surface. Knowledge regarding the role of the ocular surface microbiome in allergic disease is important to guide development of targets for future therapeutic interventions.
Identifiants
pubmed: 37459276
doi: 10.1097/ACI.0000000000000930
pii: 00130832-990000000-00074
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
376-382Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Références
Zegans ME, Van Gelder RN. Considerations in understanding the ocular surface microbiome. Am J Ophthalmol 2014; 158:420–422.
Doan T, Akileswaran L, Andersen D, et al. Paucibacterial microbiome and resident DNA virome of the healthy conjunctiva. Invest Ophthalmol Vis Sci 2016; 57:5116–5126.
Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207–214.
Human Microbiome Project Consortium. A framework for human microbiome research. Nature 2012; 486:215–221.
Kittipibul T, Puangsricharern V, Chatsuwan T. Comparison of the ocular microbiome between chronic Stevens-Johnson syndrome patients and healthy subjects. Sci Rep 2020; 10:4353.
Gupta N, Chhibber-Goel J, Gupta Y, et al. Ocular conjunctival microbiome profiling in dry eye disease: a case–control pilot study. Indian J Ophthalmol 2023; 71:1574–1581.
Jing D, Jiang X, Ren X, et al. Metagenomic nanopore sequencing of ocular microbiome in patients with meibomian gland dysfunction. Front Med (Lausanne) 2022; 9:1045990.
Shivaji S, Jayasudha R, Chakravarthy SK, et al. Alterations in the conjunctival surface bacterial microbiome in bacterial keratitis patients. Exp Eye Res 2021; 203:108418.
Delbeke H, Casteels I, Joossens M. DNA extraction protocol impacts ocular surface microbiome profile. Front Microbiol 2023; 14:1128917.
Peter VG, Morandi SC, Herzog EL, et al. Investigating the ocular surface microbiome: what can it tell us? Clin Ophthalmol 2023; 17:259–271.
Chang CJ, Winn BJ. Perturbations of the ocular surface microbiome and their effect on host immune function. Curr Opin Ophthalmol 2023; 34:181–188.
Deng Y, Wen X, Hu X, et al. Geographic difference shaped human ocular surface metagenome of young han chinese from beijing, wenzhou, and guangzhou cities. Invest Ophthalmol Vis Sci 2020; 61:47.
Petrillo F, Pignataro D, Lavano MA, et al. Current evidence on the ocular surface microbiota and related diseases. Microorganisms 2020; 8:1033.
St Leger AJ, Desai JV, Drummond RA, et al. An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal gammadelta T cells. Immunity 2017; 47:148–158. e5.
Cavuoto KM, Stradiotto AC, Galor A. Role of the ocular surface microbiome in allergic disease. Curr Opin Allergy Clin Immunol 2019; 19:482–487.
Garza A, Diaz G, Hamdan M, et al. Homeostasis and defense at the surface of the eye. the conjunctival microbiota. Curr Eye Res 2021; 46:1–6.
Wang C, Schaefer L, Bian F, et al. Dysbiosis modulates ocular surface inflammatory response to liposaccharide. Invest Ophthalmol Vis Sci 2019; 60:4224–4233.
DeGruttola AK, Low D, Mizoguchi A, Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm Bowel Dis 2016; 22:1137–1150.
Fu Y, Wu J, Wang D, et al. Metagenomic profiling of ocular surface microbiome changes in Demodex blepharitis patients. Front Cell Infect Microbiol 2022; 12:922753.
Song H, Xiao K, Chen Z, Long Q. Analysis of conjunctival sac microbiome in dry eye patients with and without Sjogren's syndrome. Front Med (Lausanne) 2022; 9:841112.
Ali SM, Abdel-Gawad MM, Azab M, et al. Comparative analysis of the ocular surface microbiome in type-1, type-2 diabetes-mellitus and healthy individuals. J Appl Microbiol 2023; lxad096.
Suwajanakorn O, Puangsricharern V, Kittipibul T, Chatsuwan T. Ocular surface microbiome in diabetes mellitus. Sci Rep 2022; 12:21527.
Perez-Losada M, Castro-Nallar E, Laerte Boechat J, et al. Nasal bacteriomes of patients with asthma and allergic rhinitis show unique composition, structure, function and interactions. Microorganisms 2023; 11:683.
Valverde-Molina J, Garcia-Marcos L. Microbiome and asthma: microbial dysbiosis and the origins, phenotypes, persistence, and severity of asthma. Nutrients 2023; 15:486.
Leonardi A, Castegnaro A, Valerio AL, Lazzarini D. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study. Curr Opin Allergy Clin Immunol 2015; 15:482–488.
Kelkar J, Kelkar A, Thakur P, et al. The epidemiology and disease pattern of pediatric ocular morbidities in Western India: the National Institute of OphthalMology AmBlyopia StUdy in Indian Paediatric EyeS (NIMBUS) study report 1. Indian J Ophthalmol 2023; 71:941–945.
Villegas BV, Benitez-Del-Castillo JM. Current knowledge in allergic conjunctivitis. Turk J Ophthalmol 2021; 51:45–54.
Singhal D, Sahay P, Maharana PK, et al. Vernal Keratoconjunctivitis. Surv Ophthalmol 2019; 64:289–311.
Roy N, Levanon S, Asbell PA. Potential biomarkers for allergic conjunctival diseases. Eye Contact Lens 2020; 46: (Suppl 2): S109–S121.
Chong-Neto HJ, Rosario C, Leonardi A, Filho NAR. Ocular allergy in children and adolescents. Allergol Immunopathol (Madr) 2022; 50 (Pt 1):30–36.
Dogru M, Nakagawa N, Tetsumoto K, et al. Ocular surface disease in atopic dermatitis. Jpn J Ophthalmol 1999; 43:53–57.
Fukuda K, Kishimoto T, Sumi T, et al. Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye. Allergol Int 2023; 72:234–244.
Leonardi A, Fregona IA, Plebani M, et al. Th1- and Th2-type cytokines in chronic ocular allergy. Graefes Arch Clin Exp Ophthalmol 2006; 244:1240–1245.
Kim SE, Nowak V, Quartilho A, et al. Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years. Cochrane Database Syst Rev 2020; 10:CD013298.
Liborio AM, Nishiwaki-Dantas MC, Mimica LM, et al. Conjunctival microbiota in patients with ocular allergy. Arq Bras Oftalmol 2005; 68:824–827.
Yau JW, Hou J, Tsui SKW, et al. Characterization of ocular and nasopharyngeal microbiome in allergic rhinoconjunctivitis. Pediatr Allergy Immunol 2019; 30:624–631.
Wang Y, Li X, Gu S, Fu J. Characterization of dysbiosis of the conjunctival microbiome and nasal microbiome associated with allergic rhinoconjunctivitis and allergic rhinitis. Front Immunol 2023; 14:1079154.
Gomes JAP, Frizon L, Demeda VF. Ocular surface microbiome in health and disease. Asia Pac J Ophthalmol (Phila) 2020; 9:505–511.
Song H, Xiao K, Min H, et al. Characterization of conjunctival sac microbiome from patients with allergic conjunctivitis. J Clin Med 2022; 11:
Liang Q, Li J, Zhang S, et al. Characterization of conjunctival microbiome dysbiosis associated with allergic conjunctivitis. Allergy 2021; 76:596–600.
Zarzuela JC, Reinoso R, Armentia A, et al. Conjunctival intraepithelial lymphocytes, lacrimal cytokines and ocular commensal microbiota: analysis of the three main players in allergic conjunctivitis. Front Immunol 2022; 13:911022.
Inada N, Shoji J, Harata G, et al. Dysbiosis of ocular surface microbiota in patients with refractive allergic conjunctival diseases. Cornea 2021; 41:1232–1241.
Hur MS, Lee JS, Jang M, et al. Analysis of the conjunctival microbiome in patients with atopic keratoconjunctivitis and healthy individuals. Ann Dermatol 2021; 33:163–169.
Leonardi A, Modugno RL, Cavarzeran F, Rosani U. Metagenomic analysis of the conjunctival bacterial and fungal microbiome in vernal keratoconjunctivitis. Allergy 2021; 76:3215–3217.
Vishwakarma P, Mitra S, Beuria T, et al. Comparative profile of ocular surface microbiome in vernal keratoconjunctivitis patients and healthy subjects. Graefes Arch Clin Exp Ophthalmol 2021; 259:1925–1933.
Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, et al. Conjunctival allergen provocation test: guidelines for daily practice. Allergy 2017; 72:43–54.
Dupuis P, Prokopich CL, Hynes A, Kim H. A contemporary look at allergic conjunctivitis. Allergy Asthma Clin Immunol 2020; 16:5.
Bielory L, Schoenberg D. Emerging therapeutics for ocular surface disease. Curr Allergy Asthma Rep 2019; 19:16.
Rasmussen MLR, Schou MG, Bach-Holm D, et al. Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta-analyses. Acta Ophthalmol 2022; 100:35–44.
Dahlmann-Noor A, Bonini S, Bremond-Gignac D, et al. Novel insights in the management of vernal keratoconjunctivitis (VKC): European Expert Consensus using a modified nominal group technique. Ophthalmol Ther 2023; 12:1207–1222.
Ohtani S, Shimizu K, Nejima R, et al. Conjunctival bacteria flora of glaucoma patients during long-term administration of prostaglandin analog drops. Invest Ophthalmol Vis Sci 2017; 58:3991–3996.
Zhong Y, Fang X, Wang X, et al. Effects of sodium hyaluronate eye drops with or without preservatives on ocular surface bacterial microbiota. Front Med (Lausanne) 2022; 9:793565.
Zhang Z, Liu L, Tang H, et al. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. Am J Transplant 2018; 18:1646–1656.
Gibson CM, Childs-Kean LM, Naziruddin Z, Howell CK. The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation. Transpl Infect Dis 2021; 23:e13397.
Wongpiyabovorn J, Soonthornchai W, Wilantho A, et al. Effect of tacrolimus on skin microbiome in atopic dermatitis. Allergy 2019; 74:1400–1406.
Luo C, Peng S, Li M, et al. The efficacy and safety of probiotics for allergic rhinitis: a systematic review and meta-analysis. Front Immunol 2022; 13:848279.
Climent E, Martinez-Blanch JF, Llobregat L, et al. Changes in gut microbiota correlates with response to treatment with probiotics in patients with atopic dermatitis. a post hoc analysis of a clinical trial. Microorganisms 2021; 9:854.
Iovieno A, Lambiase A, Sacchetti M, et al. Preliminary evidence of the efficacy of probiotic eye-drop treatment in patients with vernal keratoconjunctivitis. Graefes Arch Clin Exp Ophthalmol 2008; 246:435–441.